Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BINIMETINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BINIMETINIB: Safety Overview

Metric BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS BINIMETINIB
Total FAERS Reports 176 6,914
Deaths Reported 0 1,069
Death Rate N/A 15.5%
Hospitalizations 110 1,990
Average Patient Age 66.0 yrs 63.0 yrs
% Female Patients 91.7% 47.7%
FDA Approval Date N/A Jun 27, 2018
Manufacturer N/A Array BioPharma Inc.
Route N/A ORAL
Marketing Status N/A Prescription